Page last updated: 2024-09-05

adenosine 2',5'-diphosphate and inositol 1,4,5-trisphosphate

adenosine 2',5'-diphosphate has been researched along with inositol 1,4,5-trisphosphate in 1 studies

Compound Research Comparison

Studies
(adenosine 2',5'-diphosphate)
Trials
(adenosine 2',5'-diphosphate)
Recent Studies (post-2010)
(adenosine 2',5'-diphosphate)
Studies
(inositol 1,4,5-trisphosphate)
Trials
(inositol 1,4,5-trisphosphate)
Recent Studies (post-2010) (inositol 1,4,5-trisphosphate)
29026,6001589

Protein Interaction Comparison

ProteinTaxonomyadenosine 2',5'-diphosphate (IC50)inositol 1,4,5-trisphosphate (IC50)
Inositol-trisphosphate 3-kinase ARattus norvegicus (Norway rat)4.45
Inositol 1,4,5-trisphosphate receptor type 2Homo sapiens (human)0.03
Inositol 1,4,5-trisphosphate receptor type 3Homo sapiens (human)0.03
Inositol 1,4,5-trisphosphate receptor type 1Homo sapiens (human)0.03

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boeynaems, JM; Communi, D; Robaye, B1

Other Studies

1 other study(ies) available for adenosine 2',5'-diphosphate and inositol 1,4,5-trisphosphate

ArticleYear
Pharmacological characterization of the human P2Y11 receptor.
    British journal of pharmacology, 1999, Volume: 128, Issue:6

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Inositol 1,4,5-Trisphosphate; Phosphoadenosine Phosphosulfate; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Recombinant Fusion Proteins; Suramin; Theophylline; Thionucleotides; Time Factors; Triazines; Tumor Cells, Cultured

1999